Outcomes of Anti-CD19 Chimeric Antigen Receptor (CAR) T-cell Patients: Real World Experience in Lymphoma Patients Read more
Outcomes and Prognostic Factors of patients diagnosed with high-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study Read more
Clinical Efficacy and Mechanisms of Resistance to Polatuzumab Vedotin in Patients with Large B-cell Lymphoma After CAR T-cell therapy Read more
Outcomes of patients with aggressive B-cell non-Hodgkin s lymphoma who undergo hematopoietic cell transplantation after CAR T-cell therapy Read more
Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): A Phase II Study with Safety Lead-in Read more
A randomized, open-label study evaluating the efficacy and safety of cemacabtagene ansegedleucel in participants with minimal residual disease after response to first line therapy for large B-cell lymphoma ALPHA3) Read more
Phase IB/II of CPX-351 as maintenance therapy in AML patients ineligible for bone marrow transplantation Read more
An Open-Label, Phase 1/2 Study of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004) Read more
